CIPLA - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 4.0
Show all parameters (20 more)
🧾 Chart Verdict
Optimal entry zone could be between 1,350 ₹ – 1,375 ₹ if a short-term bounce occurs, utilizing the recent high as support. An exit strategy would be to set a stop-loss order around 1,320 ₹ - 1,300 ₹ to protect profits during potential downside movement given the negative MACD and RSI signals. Overall, the stock maintains a bullish lean based on revenue growth and USFDA approvals, but requires careful monitoring for signs of weakening momentum or increased selling pressure.
✅ Positive
The price is currently trading near its recent high of 1,673 ₹, indicating strong support and potential upward momentum. Volume remains elevated compared to the one-week average, suggesting sustained interest in the stock.
⚠️ Limitation
Despite the positive momentum, the RSI reading of 48.2 suggests that the stock hasn’t yet entered overbought territory, but it also doesn't signal extreme bullishness. The MACD is negative and relatively weak, hinting at potential resistance ahead, and a break below current levels could trigger further downside pressure.
📉 Company Negative News
Recent news reports indicate a -2.35% decrease in FII holding and a 2.64% increase in DII holdings, suggesting reduced institutional investor confidence, but overall positive FY26 revenue growth. The scanx.trade article regarding the GST inspection concluded with no material impact, offering reassurance after initial concern.
📈 Company Positive News
Cipla achieved record revenue of ₹28,000 crore in FY26, significantly exceeding previous figures. Furthermore, the USFDA approval for generic Ventolin inhaler is positive news and should drive further growth.
🏭 Industry
The pharmaceutical sector is currently characterized by moderate growth driven by increasing healthcare spending and generic drug demand. The industry PE of 34.8 suggests that Cipla’s valuation is in line with its peers, reflecting reasonable expectations for future earnings growth within the broader market trends.